European Institute of Science AB Stock

Equities

EURI B

SE0020357457

Biotechnology & Medical Research

End-of-day quote NORDIC GROWTH MARKET 06:00:00 2024-05-13 pm EDT 5-day change 1st Jan Change
3.7 SEK -13.15% Intraday chart for European Institute of Science AB -13.15% -70.82%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site
Sales 2021 536K 49.75K Sales 2022 529K 49.11K Capitalization 14.93M 1.39M
Net income 2021 -2M -186K Net income 2022 -2M -186K EV / Sales 2021 10.1 x
Net cash position 2021 3M 279K Net cash position 2022 4.29M 398K EV / Sales 2022 20.1 x
P/E ratio 2021
-2.82 x
P/E ratio 2022
-1.48 x
Employees 2
Yield 2021 *
-
Yield 2022
-
Free-Float 5.69%
More Fundamentals * Assessed data
Dynamic Chart
European Institute of Science AB Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
European Institute of Science AB Reports Earnings Results for the Full Year Ended December 31, 2023 CI
European Institute of Science AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
European Institute of Science AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
European Institute of Science AB Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
European Institute of Science AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2022 CI
European Institute of Science AB Reports Earnings Results for the Full Year Ended December 31, 2022 CI
European Institute of Science AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
European Institute of Science AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
European Institute of Science AB Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
European Institute of Science AB Reports Earnings Results for the Full Year Ended December 31, 2021 CI
European Institute of Science AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2021 CI
European Institute of Science AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021 CI
European Institute of Science AB Reports Earnings Results for the Second Quarter Ended June 30, 2021 CI
European Institute of Science AB Reports Earnings Results for the First Quarter Ended March 31, 2021 CI
More news
1 day-13.15%
1 week-13.15%
Current month-2.63%
1 month+4.52%
3 months-56.98%
6 months-64.76%
Current year-70.82%
More quotes
1 week
3.52
Extreme 3.52
4.78
1 month
3.50
Extreme 3.5
4.78
Current year
3.50
Extreme 3.5
18.00
1 year
3.50
Extreme 3.5
32.00
3 years
3.50
Extreme 3.5
370.00
5 years
3.50
Extreme 3.5
490.00
10 years
3.50
Extreme 3.5
3 600.00
More quotes
Managers TitleAgeSince
Founder 58 89-12-31
President 49 03-12-31
Members of the board TitleAgeSince
Chairman 80 03-12-31
Founder 58 89-12-31
President 49 03-12-31
More insiders
Date Price Change Volume
24-05-14 3.7 -13.15% 87
24-05-13 4.26 0.00% 372
24-05-08 4.26 0.00% 517
24-05-07 4.26 +12.11% 1,294

End-of-day quote NORDIC GROWTH MARKET, May 13, 2024

More quotes
European Institute of Science AB (EURIS) is a Sweden-based commercial research center. The Company, through its wholly owned subsidiary, ScienceHouse Lund AB is engaged in the research, development, manufacturing, sales and marketing of medical technology, health care, cosmetics and personal care, biotechnology, energy, education and entertainment products and methods. Additionally, it is engaged in the investment in high-technology companies, as well as in leasing and management of properties. As of December 31, 2011, the Company’s investments and project royalties included LifeAssays AB (publ), Biotech-IgG AB and Implementa Hebe AB (publ). The Company’s products include liquid chromatography equipment for affinity purification of proteins and antibodies, and a range of products obtained from pooled human or animal plasma.
More about the company
  1. Stock Market
  2. Equities
  3. EURI B Stock
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW